Dassault Systèmes: Strong Q3 performance with improved FY26 objectives and a step change in Life Sciences
Filed with Euronext · · 25 pages · English
Summary by 6ix AI
The company also announced the completion of the ArisGlobal acquisition, which is expected to enhance its capabilities in Life Sciences. Management raised the full-year revenue and operating margin objectives, indicating confidence in continued growth and performance improvements.
Written by 6ix AI from the company’s filing. How 6ix writes summaries
Watch Dassault Systemes' latest callDassault Systemes (Euronext:DSY) Q2 2026 Earnings Call · Replay · Jul 23Read the transcript of Dassault Systemes (Euronext:DSY) Q2 2026 Earnings CallIn the deck
Story so far
- Dassault Systemes to acquire ArisGlobal, creating a unified AI intelligence platform for the Life Sciences industry connecting molecule, patient and real-world outcomes
- Dassault Systèmes to Acquire ArisGlobal, Creating a Unified AI Intelligence Platform for the Life Sciences Industry Connecting Molecule, Patient and Real-World Outcomes
- Dassault Systèmes: Solid Q2 results and confirming full-year objectives - Delivering AI-native solutions and expanding in Life Sciences with the acquisition of ArisGlobal
Earlier from Dassault Systemes
- Dassault Systèmes: declaration of the number of outstanding shares and voting rights as of September 30, 2026
- Dassault Systèmes: declaration of the number of outstanding shares and voting rights as of August 31, 2026
- Dassault Systèmes déclaration du nombre d'actions et de droits de vote au 31 août 2026
- SOLIZE PARTNERS and Dassault Systèmes Form Partnership to Accelerate Digital Transformation in Manufacturing
- Dassault Systèmes: declaration of the number of outstanding shares and voting rights as of July 31, 2026
Follow Dassault Systemes into a list and get an email when it puts out news.
Follow Dassault Systemes